These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 15070963)

  • 1. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
    Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
    Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications.
    Ezzat S; Zheng L; Winer D; Asa SL
    Mol Endocrinol; 2006 Nov; 20(11):2965-75. PubMed ID: 16857743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: a mechanism underlying pituitary neoplasia.
    Ezzat S; Zheng L; Asa SL
    Mol Endocrinol; 2004 Oct; 18(10):2543-52. PubMed ID: 15231874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter.
    Ezzat S; Yu S; Asa SL
    Am J Pathol; 2003 Sep; 163(3):1177-84. PubMed ID: 12937159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication.
    Pereira-Lima JF; Marroni CP; Pizarro CB; Barbosa-Coutinho LM; Ferreira NP; Oliveira MC
    Neuroendocrinology; 2004 Mar; 79(3):119-24. PubMed ID: 15103224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
    Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
    Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study.
    Ramírez C; Cheng S; Vargas G; Asa SL; Ezzat S; González B; Cabrera L; Guinto G; Mercado M
    J Clin Endocrinol Metab; 2012 May; 97(5):1745-51. PubMed ID: 22419713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptors alpha and beta immunohistochemical expression: clinicopathological correlations in pituitary adenomas.
    Manoranjan B; Salehi F; Scheithauer BW; Rotondo F; Kovacs K; Cusimano MD
    Anticancer Res; 2010 Jul; 30(7):2897-904. PubMed ID: 20683030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular localization of basic fibroblast growth factor and fibroblast growth factor receptor 1 in pituitary adenomas.
    Fukui S; Otani N; Nawashiro H; Yano A; Nomura N; Miyazawa T; Ohnuki A; Tsuzuki N; Katoh H; Ishihara S; Shima K
    Brain Tumor Pathol; 2002; 19(1):23-9. PubMed ID: 12455885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4.
    Yu S; Asa SL; Weigel RJ; Ezzat S
    J Biol Chem; 2003 May; 278(22):19597-602. PubMed ID: 12642581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression in human pituitary tumors.
    Vidal S; Kovacs K; Bell D; Horvath E; Scheithauer BW; Lloyd RV
    Cancer; 2003 Jun; 97(11):2814-21. PubMed ID: 12767095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
    Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
    Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas.
    Mastronardi L; Guiducci A; Puzzilli F
    BMC Cancer; 2001; 1():12. PubMed ID: 11570981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53.
    Kasuki Jomori de Pinho L; Vieira Neto L; Armondi Wildemberg LE; Gasparetto EL; Marcondes J; de Almeida Nunes B; Takiya CM; Gadelha MR
    Neuroendocrinology; 2011; 94(1):39-48. PubMed ID: 21178332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary macroadenomas (>3 cm) in young adulthood: Pathologic and proliferative characteristics.
    Öngürü Ö; Düz B; Şimşek H; Günal A; Gönül E
    Neurol Neurochir Pol; 2015; 49(4):212-6. PubMed ID: 26188936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.